List view / Grid view
Researchers demonstrated that ABCC4 is essential to signalling in the SHH subgroup of medulloblastomas and when expression was reduced in mice, the tumours shrank.
Scientists have produced hundreds of organoids which they say could be produced on a large-scale as a low-cost tissue model to help research and test new medulloblastoma therapies.
A new weakness found in medulloblastoma could lead to more personalised medicine and improved treatment for some patients.
Researchers raise hopes for developing a combination targeted therapy to treat medulloblastoma and other tumours...
St. Jude Children’s Research Hospital discovery of a regulatory enzyme working at the primary cilium could lead to treatments for the brain tumour medulloblastoma.
